 | • レポートコード：20QY06-05063 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、共役ワクチンのグローバル市場について種類別（Hibワクチン、髄膜炎菌ワクチン、肺炎球菌ワクチン、その他）、用途別（子供、大人）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・共役ワクチン市場の概要 ・世界の主要地域別共役ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の共役ワクチン市場規模2015-2026：種類別（Hibワクチン、髄膜炎菌ワクチン、肺炎球菌ワクチン、その他） ・世界の共役ワクチン市場規模2015-2026：用途別（子供、大人） ・共役ワクチンの北米市場規模2015-2020 ・共役ワクチンのヨーロッパ市場規模2015-2020 ・共役ワクチンの中国市場規模2015-2020 ・共役ワクチンの日本市場規模2015-2020 ・共役ワクチンの東南アジア市場規模2015-2020 ・共役ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、GSK、Sanofi、Merck、Walvax Biotechnology、Royal (Wuxi) Bio-Pharmaceutical、Bharat Biotech、Zhifei Biologic） ・共役ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・共役ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Conjugate Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Conjugate Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Conjugate Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Conjugate Vaccine industry.
Based on our recent survey, we have several different scenarios about the Conjugate Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 9415 million in 2019. The market size of Conjugate Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Conjugate Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Conjugate Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Conjugate Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Conjugate Vaccine market. The report also includes nautical information, where it shows Conjugate Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Conjugate Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Conjugate Vaccine market.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
Geographical Analysis:
Based on region, the global Conjugate Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Conjugate Vaccine market are
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Segment by Type
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Segment by Application
Children
Adult
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Conjugate Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Conjugate Vaccine market.
• The market share of the global Conjugate Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Conjugate Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Conjugate Vaccine market.
1 Conjugate Vaccine Market Overview
1.1 Conjugate Vaccine Product Scope
1.2 Conjugate Vaccine Segment by Type
1.2.1 Global Conjugate Vaccine Sales by Type (2020-2026)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Conjugate Vaccine Segment by Application
1.3.1 Global Conjugate Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Children
1.3.3 Adult
1.4 Conjugate Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Conjugate Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Conjugate Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Conjugate Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Conjugate Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Conjugate Vaccine Industry
1.5.1.1 Conjugate Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Conjugate Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Conjugate Vaccine Players to Combat Covid-19 Impact
2 Conjugate Vaccine Estimate and Forecast by Region
2.1 Global Conjugate Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Conjugate Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Conjugate Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Conjugate Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Conjugate Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Conjugate Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Conjugate Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Conjugate Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Conjugate Vaccine Estimates and Projections (2015-2026)
2.4.3 China Conjugate Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Conjugate Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Conjugate Vaccine Estimates and Projections (2015-2026)
2.4.6 India Conjugate Vaccine Estimates and Projections (2015-2026)
3 Global Conjugate Vaccine Competition Landscape by Players
3.1 Global Top Conjugate Vaccine Players by Sales (2015-2020)
3.2 Global Top Conjugate Vaccine Players by Revenue (2015-2020)
3.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjugate Vaccine as of 2019)
3.4 Global Conjugate Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Conjugate Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Conjugate Vaccine Players (Opinion Leaders)
4 Global Conjugate Vaccine Market Size by Type
4.1 Global Conjugate Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Conjugate Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Conjugate Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Conjugate Vaccine Price by Type (2014-2020)
4.2 Global Conjugate Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Conjugate Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Conjugate Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Conjugate Vaccine Price Forecast by Type (2021-2026)
5 Global Conjugate Vaccine Market Size by Application
5.1 Global Conjugate Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Conjugate Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Conjugate Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Conjugate Vaccine Price by Application (2015-2020)
5.2 Global Conjugate Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Conjugate Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Conjugate Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Conjugate Vaccine Price Forecast by Application (2021-2026)
3 North America Conjugate Vaccine Market Facts & Figures
3.2 North America Conjugate Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Conjugate Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Conjugate Vaccine Sales Market Share by Application (2015-2020)
4 Europe Conjugate Vaccine Market Facts & Figures
4.2 Europe Conjugate Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Conjugate Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Conjugate Vaccine Sales Market Share by Application (2015-2020)
5 China Conjugate Vaccine Market Facts & Figures
5.2 China Conjugate Vaccine Sales Market Share by Company (2015-2020)
5.3 China Conjugate Vaccine Sales Market Share by Type (2015-2020)
5.4 China Conjugate Vaccine Sales Market Share by Application (2015-2020)
6 Japan Conjugate Vaccine Market Facts & Figures
6.2 Japan Conjugate Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Conjugate Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Conjugate Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Conjugate Vaccine Market Facts & Figures
7.2 Southeast Asia Conjugate Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Conjugate Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Conjugate Vaccine Sales Market Share by Application (2015-2020)
8 India Conjugate Vaccine Market Facts & Figures
8.2 India Conjugate Vaccine Sales Market Share by Company (2015-2020)
8.3 India Conjugate Vaccine Sales Market Share by Type (2015-2020)
8.4 India Conjugate Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Conjugate Vaccine Business
12.1 Pfizer
12.1.1 Pfizer Conjugate Vaccine Corporation Information
12.1.2 Pfizer Conjugate Vaccine Business Overview and Total Revenue
12.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Conjugate Vaccine Products Offered
12.1.5 Pfizer Recent Development
12.2 GSK
12.2.1 GSK Conjugate Vaccine Corporation Information
12.2.2 GSK Conjugate Vaccine Business Overview and Total Revenue
12.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Conjugate Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi
12.3.1 Sanofi Conjugate Vaccine Corporation Information
12.3.2 Sanofi Conjugate Vaccine Business Overview and Total Revenue
12.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Conjugate Vaccine Products Offered
12.3.5 Sanofi Recent Development
12.4 Merck
12.4.1 Merck Conjugate Vaccine Corporation Information
12.4.2 Merck Conjugate Vaccine Business Overview and Total Revenue
12.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Conjugate Vaccine Products Offered
12.4.5 Merck Recent Development
12.5 Walvax Biotechnology
12.5.1 Walvax Biotechnology Conjugate Vaccine Corporation Information
12.5.2 Walvax Biotechnology Conjugate Vaccine Business Overview and Total Revenue
12.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Walvax Biotechnology Conjugate Vaccine Products Offered
12.5.5 Walvax Biotechnology Recent Development
12.6 Royal (Wuxi) Bio-Pharmaceutical
12.6.1 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Corporation Information
12.6.2 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Business Overview and Total Revenue
12.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered
12.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
12.7 Bharat Biotech
12.7.1 Bharat Biotech Conjugate Vaccine Corporation Information
12.7.2 Bharat Biotech Conjugate Vaccine Business Overview and Total Revenue
12.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bharat Biotech Conjugate Vaccine Products Offered
12.7.5 Bharat Biotech Recent Development
12.8 Zhifei Biologic
12.8.1 Zhifei Biologic Conjugate Vaccine Corporation Information
12.8.2 Zhifei Biologic Conjugate Vaccine Business Overview and Total Revenue
12.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Zhifei Biologic Conjugate Vaccine Products Offered
12.8.5 Zhifei Biologic Recent Development
13 Conjugate Vaccine Manufacturing Cost Analysis
13.1 Conjugate Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Conjugate Vaccine
13.4 Conjugate Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Conjugate Vaccine Distributors List
14.3 Conjugate Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Conjugate Vaccine Sales (Million Unit) Growth Rate by Type (2020-2026)
Table 2. Global Conjugate Vaccine Sales (Million Unit) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Conjugate Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Conjugate Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Conjugate Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Conjugate Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Conjugate Vaccine Sales (Million Unit) by Region (2015-2020)
Table 10. Global Conjugate Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Conjugate Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Conjugate Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Conjugate Vaccine Sales (Million Unit) Forecast by Region (2021-2026)
Table 14. Global Conjugate Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Conjugate Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Conjugate Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Conjugate Vaccine (Million Unit) of Key Companies (2015-2020)
Table 18. Global Conjugate Vaccine Sales Share by Company (2015-2020)
Table 19. Global Conjugate Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Conjugate Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjugate Vaccine as of 2019)
Table 22. Global Conjugate Vaccine Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Conjugate Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Conjugate Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Conjugate Vaccine Players
Table 27. Global Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 28. Global Conjugate Vaccine Sales Share by Type (2015-2020)
Table 29. Global Conjugate Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Conjugate Vaccine Price (Million Unit) by Type (2015-2020)
Table 31. Global Conjugate Vaccine Sales Share by Type (2021-2026)
Table 32. Global Conjugate Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Conjugate Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Conjugate Vaccine Price (Million Unit) by Type (2021-2026)
Table 35. Global Conjugate Vaccine Sales (Million Unit) by Application (2015-2020)
Table 36. Global Conjugate Vaccine Sales Share by Application (2015-2020)
Table 37. Global Conjugate Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Conjugate Vaccine Price (Million Unit) by Application (2015-2020)
Table 39. Global Conjugate Vaccine Sales (Million Unit) by Application (2021-2026)
Table 40. Global Conjugate Vaccine Sales Share by Application (2021-2026)
Table 41. Global Conjugate Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Conjugate Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Conjugate Vaccine Price (Million Unit) by Application (2021-2026)
Table 44. United States Conjugate Vaccine Sales (Million Unit) by Company (2015-2020)
Table 45. United States Conjugate Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 47. United States Conjugate Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Conjugate Vaccine Sales (Million Unit) by Application (2015-2020)
Table 49. United States Conjugate Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Conjugate Vaccine Sales (Million Unit) by Company (2015-2020)
Table 51. Europe Conjugate Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 53. Europe Conjugate Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Conjugate Vaccine Sales (Million Unit) by Application (2015-2020)
Table 55. Europe Conjugate Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Conjugate Vaccine Sales (Million Unit) by Company (2015-2020)
Table 57. China Conjugate Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 59. China Conjugate Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Conjugate Vaccine Sales (Million Unit) by Application (2015-2020)
Table 61. China Conjugate Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Conjugate Vaccine Sales (Million Unit) by Company (2015-2020)
Table 63. Japan Conjugate Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 65. Japan Conjugate Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Conjugate Vaccine Sales (Million Unit) by Application (2015-2020)
Table 67. Japan Conjugate Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Conjugate Vaccine Sales (Million Unit) by Company (2015-2020)
Table 69. Southeast Asia Conjugate Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 71. Southeast Asia Conjugate Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 73. Southeast Asia Conjugate Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Conjugate Vaccine Sales (Million Unit) by Company (2015-2020)
Table 75. India Conjugate Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Conjugate Vaccine Sales (Million Unit) by Type (2015-2020)
Table 77. India Conjugate Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Conjugate Vaccine Sales (Million Unit) by Application (2015-2020)
Table 79. India Conjugate Vaccine Sales Market Share by Application (2015-2020)
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Conjugate Vaccine Product
Table 84. Pfizer Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GSK Conjugate Vaccine Product
Table 89. GSK Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Sanofi Conjugate Vaccine Product
Table 94. Sanofi Recent Development
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck Conjugate Vaccine Product
Table 99. Merck Recent Development
Table 100. Walvax Biotechnology Corporation Information
Table 101. Walvax Biotechnology Description and Business Overview
Table 102. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Walvax Biotechnology Conjugate Vaccine Product
Table 104. Walvax Biotechnology Recent Development
Table 105. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 106. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 107. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 109. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 110. Bharat Biotech Corporation Information
Table 111. Bharat Biotech Description and Business Overview
Table 112. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bharat Biotech Conjugate Vaccine Product
Table 114. Bharat Biotech Recent Development
Table . Zhifei Biologic Corporation Information
Table . Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Zhifei Biologic Description and Business Overview
Table . Zhifei Biologic Conjugate Vaccine Product
Table . Zhifei Biologic Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Conjugate Vaccine Distributors List
Table 123. Conjugate Vaccine Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Conjugate Vaccine Product Picture
Figure 2. Global Conjugate Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Conjugate Vaccine Market Share by Application in 2020 & 2026
Figure 6. Children Examples
Figure 7. Adult Examples
Figure 8. Global Conjugate Vaccine Sales (Million Unit) Growth Rate (2015-2026)
Figure 9. Global Conjugate Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Conjugate Vaccine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Conjugate Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Conjugate Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Conjugate Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Conjugate Vaccine Sales (Million Unit) Growth Rate (2015-2026)
Figure 15. Europe Conjugate Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Conjugate Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Conjugate Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Conjugate Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Conjugate Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Conjugate Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Conjugate Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Conjugate Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Conjugate Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Conjugate Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Conjugate Vaccine Players Market Share by Revenue in Conjugate Vaccine 2015 & 2019
Figure 26. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Conjugate Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Conjugate Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Conjugate Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Conjugate Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Conjugate Vaccine Sales Market Share by Type in 2019
Figure 32. United States Conjugate Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Conjugate Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Conjugate Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Conjugate Vaccine Sales Market Share by Application in 2019
Figure 36. China Conjugate Vaccine Sales Market Share by Company in 2019
Figure 37. China Conjugate Vaccine Sales Market Share by Type in 2019
Figure 38. China Conjugate Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Conjugate Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Conjugate Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Conjugate Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Conjugate Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Conjugate Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Conjugate Vaccine Sales Market Share by Application in 2019
Figure 45. India Conjugate Vaccine Sales Market Share by Company in 2019
Figure 46. India Conjugate Vaccine Sales Market Share by Type in 2019
Figure 47. India Conjugate Vaccine Sales Market Share by Application in 2019
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Walvax Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Royal (Wuxi) Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Bharat Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Zhifei Biologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Conjugate Vaccine
Figure 58. Manufacturing Process Analysis of Conjugate Vaccine
Figure 59. Conjugate Vaccine Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
多価肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx …- 肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015. The second place is Europe, following North America with sales market share over 18…
- ペット用ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Pet Vaccine Market The global Pet Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Pet Vaccine Scope and Market Size The global Pet Vaccine market is segmented …
- 肺炎球菌ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019. The Pneumococ…
- 髄膜炎菌ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Meningococcal Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…